Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287931
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-25
Brief Title:
Probiotics for Gallstones in Post-bariatric Surgery Patients
Sponsor:
Shandong Linglong Yingcheng Hospital
Organization:
Shandong Linglong Yingcheng Hospital
Study Overview
Official Title:
Probiotics for Gallstones in Post-bariatric Surgery Patients
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Obesity is an increasing epidemic worldwide and has a significant impact on human health and socioeconomics Multiple studies have shown that bariatric surgery increases the risk of postoperative gallbladder stones Contributing factors to gallstone formation include gallbladder motility and bile supersaturation due to rapid weight loss and cholesterol mobilization At present the prevention and treatment of gallbladder stones in obese patients after bariatric surgery are still controversial In recent years the study of ursodeoxycholic acid in preventing gallbladder stone formation after bariatric surgery has become a research hotspot At the same time other studies have shown that taking probiotics or digestive enzymes may improve gastrointestinal symptoms and improve quality of life after bariatric surgery Therefore the purpose of this study was to determine the ability of probiotics to prevent gallstone formation after bariatric surgery and to evaluate the impact of oral probiotics on quality of life in patients after bariatric surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None